NCT00495885 - Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus | Biotech Hunter

Enrollment

848

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG

volinanserin (M100907)

oral, one tablet taken around bedtime

DRUG

Placebo

oral, one tablet taken around bedtime

Trial Locations (16)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, São Paulo

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Bogotá

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Athens

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Kuala Lumpur

Sanofi-Aventis Administrative Office, Gouda

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Midrand

Sanofi-Aventis Administrative Office, Geneva

Sanofi-Aventis Administrative Office, Taipei

Sanofi-Aventis Administrative Office, Istanbul